Clinical Trial Update: A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer [Phase 1]

View source ↗

Summary

This entry describes a Phase 1 clinical trial evaluating a CEA-targeting CAR-T cell therapy for CEA-positive advanced lung cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• CEA-targeting CAR-T therapy (CEA-targeting CAR-T cell therapy)

Snippet

Sponsor: Chongqing Precision Biotech Co., Ltd | Conditions: Advanced Lung Cancer | Phase 1 | Status: RECRUITING